The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective analysis of candidate predictive tumor biomarkers (BMs) for efficacy in the GOG-0218 trial evaluating front-line carboplatin–paclitaxel (CP) ± bevacizumab (BEV) for epithelial ovarian cancer (EOC).
 
Michael J. Birrer
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
 
YounJeong Choi
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Mark F. Brady
Consulting or Advisory Role - Aeterna Zentaris; Cel-Sci; Endocyte
 
Robert S. Mannel
Consulting or Advisory Role - Advaxis (Inst); Amgen (Inst); AstraZeneca (Inst); Endocyte (Inst); MedImmune (Inst); Oxigene (Inst)
 
Robert Allen Burger
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Champions Biotechnology; Clovis Oncology; Genentech/Roche; Janssen Research & Development; Oxigene
 
WEI WEI
No Relationships to Disclose
 
Amreen Husain
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Genentech/Roche
 
Carlos Bais
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche Pharma AG
Honoraria - Genentech/Roche
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Genentech/Roche
Other Relationship - Genentech/Roche